News

Trivitron Healthcare collaborates with Diagon- Vanguard Diagnostics

Launches Diagon’s coagulation range in India

Trivitron Healthcare has announced the launch of a new line of coagulation analyser products manufactured by Diagon. Trivitron in partnership with Diagon-Vanguard Diagnostics India announced the introduction of these products for the Indian diagnostics market following the signing of a collaboration agreement between the companies. This launch augurs well for the medical fraternity as it enhances the efficacies in clinical decision-making and broadens patient management. The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary for reducing bleeding risk in extensive surgeries, checking the efficacy of haemostatic therapies and anti-coagulant drugs.

Rajesh Patel, CEO, (IVD Business), Trivitron Healthcare said, “The range of products will complement Trivitron’s focus on supporting patient management by offering precision in clinical diagnostic fields, such as cardiology, infectious diseases, pathology, biochemistry, as well as inflammatory and autoimmune diseases”.

Chandra Ganjoo, Group CPO & Executive Director, Trivitron Healthcare said, “We are expanding and combining our organisational expertise to address the requirements of the medical community by introducing new solutions in the clinical and patient management space. We are proud to announce the enhancement of our IVD range of clinical use by enabling additional products and devices testing menu to our portfolio.”

Dr Marco van der Looij, Director of Global Business Development, Diagon Hungary & Director, Diagon-Vanguard Diagnostics India added, “We are proud to be associated with Trivitron Healthcare that has over 20 years of IVD and medical device manufacturing and selling experience in India. Together with Diagon-Vanguard-Diagnostics India, we will take our presence in the Indian market to the next level by promoting the Diagon COAG haemostasis systems line providing scalable and automated solutions for hospitals and reference laboratories. We are excited we can now offer our next generation haemostasis solutions to all laboratory sectors in India serving needs from POC testing to high-throughput requirements including critical D-Dimer test for COVID-19.”

Veena Kohli, MD, Diagon Vanguard Diagnostics India said, “Diagon-Vanguard Diagnostics India, a joint venture between long-term partners – Diagon and Vanguard Diagnostics, announces a strategic collaboration with Trivitron Healthcare. Trivitron will be a channel partner for the world-class coagulation range from Diagon. We are looking forward to jointly serving the Indian market by offering the best solutions in coagulation, customised to meet the needs of all types of testing set-ups.”

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close